James Tartaglia

发表

Multiple immunizations with attenuated poxvirus HIV type 2 recombinants and subunit boosts required for protection of rhesus macaques.

E. Paoletti, J. Tartaglia, M. Robert-Guroff, 1996, AIDS research and human retroviruses.

Highly attenuated HIV type 2 recombinant poxviruses, but not HIV-2 recombinant Salmonella vaccines, induce long-lasting protection in rhesus macaques.

J. Tartaglia, M. Robert-Guroff, A. Abimiku, 1995, AIDS research and human retroviruses.

A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA.

M. Kieny, J. Excler, T. Matthews, 1995, AIDS research and human retroviruses.

Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.

H. Sheppard, J. Tartaglia, J. Kunich, 1998, AIDS research and human retroviruses.

Physical mapping and DNA sequence analysis of the rifampicin resistance locus in vaccinia virus.

E. Paoletti, J. Tartaglia, Enzo Paoletti, 1985, Virology.

Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp 160 of HIV-1 and boosted with a recombinant gp160.

E. Paoletti, M. Kieny, J. Tartaglia, 1996, The Journal of infectious diseases.

The mode of presentation and route of administration are critical for the induction of immune responses to p53 and antitumor immunity.

J. Tartaglia, M. Chevalier, C. Hurpin, 1998, Vaccine.

Induction of cytotoxic T lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein.

E. Paoletti, W. Cox, J. Tartaglia, 1993, Virology.

Role of the vaccinia virus E3L and K3L gene products in rescue of VSV and EMCV from the effects of IFN-alpha.

E. Paoletti, J. Tartaglia, B. Jacobs, 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Nucleotide sequence analysis of a 10.5 kbp HindIII fragment of fowlpox virus: relatedness to the central portion of the vaccinia virus HindIII D region.

S. Goebel, G. P. Johnson, J. Winslow, 1990, The Journal of general virology.

Vaccinia virus rifampicin-resistance locus specifies a late 63,000 Da gene product.

E. Paoletti, J. Tartaglia, A. Piccini, 1986, Virology.

The safety and use of canarypox vectored vaccines.

E. Paoletti, J. Tartaglia, J. Excler, 1995, Developments in biological standardization.

Safety and immunogenicity of recombinants based on the genetically-engineered vaccinia strain, NYVAC.

E. Paoletti, W. Cox, J. Tartaglia, 1994, Developments in biological standardization.

Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1MN env gene.

R. Siliciano, E. Paoletti, J. Tartaglia, 1995, The Journal of infectious diseases.